SOLV NYSE
Solventum Corporation
1W: +1.0%
1M: -4.1%
3M: -0.3%
YTD: +8.7%
1Y: +18.8%
$82.98
-2.83 (-3.30%)
After Hours: $83.69 (+0.70, +0.85%)
Weekly Expected Move ±2.8%
$81
$83
$85
$88
$90
Credit Risk of going bust: lower than 68% of companies Debt: 26.6% of company value Bonds: $164.5M held by 298 funds, 78 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.97 (down 98%), Solventum Corporation would be worth roughly what it owes.
Total debt $5.29B against a stock market value of $14.61B.
Distance to default 7.31 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $2.79B (short-term plus half of long-term), stock volatility 29.7%; Altman Z 2.16. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $1.97 (down 98%), Solventum Corporation would be worth roughly what it owes.
Total debt $5.29B against a stock market value of $14.61B.
Distance to default 7.31 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $2.79B (short-term plus half of long-term), stock volatility 29.7%; Altman Z 2.16. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
8 relationships6
As Filer
counterparties named
2
As Counterparty
mentioned by others
2
Rel. Types
2024-04-04
Earliest Filing
2025-09-02
Latest Filing
acquirer: 3
partner: 3
Counterparties (Filed by SOLV)
6 relationshipsCompanies named in SOLV's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. | TMO | acquirer | Acquired Solventum's purification and filtration business for approximately $4.0 billion in cash. | 2025-09-02 | View |
| Thermo Fisher Scientific Inc. | TMO | acquirer | Agreed to acquire Solventum's purification and filtration business assets and liabilities. | 2025-06-25 | View |
| Thermo Fisher Scientific Inc. | TMO | acquirer | Acquiring Solventum's purification and filtration business for approximately $4.10 billion | 2025-02-27 | View |
| 3M Company | MMM | partner | Providing tax opinion confirmation required for transaction consummation | 2025-02-27 | View |
| 3M Company | MMM | partner | Service Provider in Transition Services Agreement | 2024-04-04 | View |
| Solventum Corporation | SOLV | partner | Service Recipient in Transition Services Agreement | 2024-04-04 | View |
Mentioned As Counterparty
2 mentionsOther companies that named SOLV in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| MMM 3M CO | partner | Counterparty in separation and distribution agreement; new independent public company formed from 3M's health care busin | 2024-04-04 | View |
| MMM 3M CO | acquirer | Target of 3M's spin-off separation, becoming an independent public company. | 2024-04-04 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-05 | Earnings Release; Exhibits | View | |
| 2026-08-05 | Regulation FD; Other Events; Exhibits | View | |
| 2026-07-20 | Officer/Director Change | View | |
| 2026-06-05 | Other Events; Exhibits | View | |
| 2026-05-27 | Officer/Director Change; Exhibits | View | |
| 2026-05-20 | Shareholder Vote | View | |
| 2026-05-05 | Earnings Release; Exhibits | View | |
| 2026-03-24 | Officer/Director Change; Exhibits | View | |
| 2026-02-26 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-12-16 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-21 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-09-08 | Other Events; Financial Statements and Exhibits | View | |
| 2025-09-02 | Completion of Acquisition or Disposition of Assets; Regulation FD Disclosure; Financial Statements a | Acquisition | View |
| 2025-08-22 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-15 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-13 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-08-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-25 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-05-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR